KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Liabilities from Discontinued Operations (2016)

Abbott Laboratories (ABT) has disclosed Liabilities from Discontinued Operations for 5 consecutive years, with 245000000.0 as the latest value for Q4 2016.

  • Quarterly Liabilities from Discontinued Operations fell 34.32% to 245000000.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was 245000000.0 through Dec 2016, down 34.32% year-over-year, with the annual reading at 245000000.0 for FY2016, 34.32% down from the prior year.
  • Liabilities from Discontinued Operations hit 245000000.0 in Q4 2016 for Abbott Laboratories, down from 597000000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 721000000.0 in Q3 2014 to a low of 1000000.0 in Q1 2014.
  • Historically, Liabilities from Discontinued Operations has averaged 348200625.0 across 4 years, with a median of 352250000.0 in 2013.
  • Biggest five-year swings in Liabilities from Discontinued Operations: plummeted 81.22% in 2014 and later soared 30000.0% in 2015.
  • Year by year, Liabilities from Discontinued Operations stood at 386000000.0 in 2013, then soared by 76.17% to 680000000.0 in 2014, then crashed by 45.15% to 373000000.0 in 2015, then plummeted by 34.32% to 245000000.0 in 2016.
  • Business Quant data shows Liabilities from Discontinued Operations for ABT at 245000000.0 in Q4 2016, 597000000.0 in Q3 2016, and 361000000.0 in Q2 2016.